Nanobiotix S.A. Adjustments For Finance Costs
Nanobiotix S.A. (NBTX) reported Adjustments For Finance Costs of EUR 4.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceCosts · last filed 2026-03-31
| Period end | Adjustments For Finance Costs 6 month | Adjustments For Finance Costs 12 month |
|---|---|---|
| 2025-12-31 | 4.09M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 842.00K EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 1.94M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 1.10M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 2.71M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | 1.01M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | 2.04M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | 1.03M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 2.22M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 1.07M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 2.12M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | 1.05M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | 1.94M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | 292.00K EUR 20-F/A · filed 2021-04-08 |